Inquiry Form

Course Details

Name of University Shinshu University
Course name Gene and Cell Therapy Researcher Training Course(Regular Graduate Course)
Target Occupation Doctors, Dentists, Pharmacists, laboratory Technicians, Employees of Pharmaceutical and Biotech Venture Companies, etc.
Length of study (period) 4 years
Human resources to be trained The program trains medical personnel who understand and practice molecular targets, immunological mechanisms of action, and side effects of cancer immunotherapy and gene therapy such as CAR-T therapy, basic and clinical researchers who can research and develop new gene and cell therapies, and drug discovery researchers who are familiar with drug discovery, CMO, CDMO, and clinical trials of cancer genome results and regenerative medicine products. In addition, the program trains physicians and technicians certified by the Japanese Society for Gene and Cell Therapy, which began its certification system in 2023.
Cooperation with professional qualifications related to cancer Accredited as a training facility for certified physicians and technicians (Japanese Society for Gene and Cell Therapy).
Characteristics of educational content In Japan, there are very few graduate school curricula that focus on gene and cell therapy. This course is a new training course for basic and clinical research physicians and drug discovery researchers that enables students to seamlessly acquire drug discovery strategies for gene and cell therapy from basic research to social implementation. In this course, lectures and exercises on gene and cell therapy research methods as well as intellectual property, drug discovery, CMC/CDMO, clinical trials, and venture start-up will be given by leading Japanese researchers, drug discovery bio ventures, and URAs. Human resource exchange with the Center for Cellular Gene Therapy at Baylor College of Medicine in the U.S. will also be conducted. This is also the first training course in Japan to train physicians and technicians certified by the Japanese Society for Gene and Cell Therapy, which will be newly established in fiscal year 2023.
Guidance system Clinical faculty with extensive experience in the development of regenerative medicine products, basic and clinical faculty from cancer-related departments, faculty from the Department of Genetic Medicine in charge of cancer genome medicine, specially appointed faculty from drug discovery bio ventures, and URA intellectual property staff will take the lead in providing multifaceted guidance.
Career path of graduates Lead cancer treatment in the Kita-Shin region and cancer research in Japan as a clinical researcher who is well versed in cancer genome medicine and cancer immunotherapy such as CAR-T therapy and immune checkpoint inhibitor therapy at a base hospital for cancer treatment, etc. Or, as a drug discovery researcher in a drug discovery company that develops regenerative medicine products, he/she will lead the Japanese medical industry.
Number of students accepted 2023 2024 2025 2026 2027 2028 Total
2 2 2 2 2 10
Acceptance Goals Based on the fact that we have been supervising one or two graduate students a year in gene and cell therapy research, we have set a target number of 10 students to be accepted into the program. The goal is to train at least five certified physicians and technicians for gene and cell therapy over the next five years, with the certified physicians assigned to base hospitals for cancer treatment and cancer treatment in Nagano Prefecture or Nagano Children’s Hospital, and the certified technicians assigned to cell processing facilities and quality inspection departments of university hospitals nationwide or to drug-discovery companies.

Back to Course List

For healthcare professionals, other graduate students, non-degree students, and the general public

Incentive Courses